MGNX
Price
$1.67
Change
-$0.07 (-4.05%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
102.39M
49 days until earnings call
XNCR
Price
$10.31
Change
-$0.08 (-0.77%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
736.05M
47 days until earnings call
Interact to see
Advertisement

MGNX vs XNCR

Header iconMGNX vs XNCR Comparison
Open Charts MGNX vs XNCRBanner chart's image
MacroGenics
Price$1.67
Change-$0.07 (-4.05%)
Volume$5.44K
Capitalization102.39M
Xencor
Price$10.31
Change-$0.08 (-0.77%)
Volume$15.83K
Capitalization736.05M
MGNX vs XNCR Comparison Chart in %
Loading...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGNX vs. XNCR commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Hold and XNCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (MGNX: $1.73 vs. XNCR: $10.39)
Brand notoriety: MGNX and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 50% vs. XNCR: 204%
Market capitalization -- MGNX: $102.39M vs. XNCR: $741.05M
MGNX [@Biotechnology] is valued at $102.39M. XNCR’s [@Biotechnology] market capitalization is $741.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.23B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 6 bullish TA indicator(s).

  • MGNX’s TA Score: 4 bullish, 6 bearish.
  • XNCR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than MGNX.

Price Growth

MGNX (@Biotechnology) experienced а +10.90% price change this week, while XNCR (@Biotechnology) price change was +22.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

MGNX is expected to report earnings on Nov 11, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($736M) has a higher market cap than MGNX($102M). MGNX YTD gains are higher at: -46.769 vs. XNCR (-54.787). MGNX has higher annual earnings (EBITDA): -26.91M vs. XNCR (-125.38M). XNCR has more cash in the bank: 444M vs. MGNX (176M). MGNX has less debt than XNCR: MGNX (37.2M) vs XNCR (67.9M). MGNX has higher revenues than XNCR: MGNX (164M) vs XNCR (147M).
MGNXXNCRMGNX / XNCR
Capitalization102M736M14%
EBITDA-26.91M-125.38M21%
Gain YTD-46.769-54.78785%
P/E RatioN/AN/A-
Revenue164M147M112%
Total Cash176M444M40%
Total Debt37.2M67.9M55%
FUNDAMENTALS RATINGS
MGNX vs XNCR: Fundamental Ratings
MGNX
XNCR
OUTLOOK RATING
1..100
7025
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6048
P/E GROWTH RATING
1..100
956
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XNCR's Valuation (75) in the Biotechnology industry is in the same range as MGNX (79). This means that XNCR’s stock grew similarly to MGNX’s over the last 12 months.

XNCR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGNX (100). This means that XNCR’s stock grew similarly to MGNX’s over the last 12 months.

XNCR's SMR Rating (97) in the Biotechnology industry is in the same range as MGNX (98). This means that XNCR’s stock grew similarly to MGNX’s over the last 12 months.

XNCR's Price Growth Rating (48) in the Biotechnology industry is in the same range as MGNX (60). This means that XNCR’s stock grew similarly to MGNX’s over the last 12 months.

XNCR's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for MGNX (95). This means that XNCR’s stock grew significantly faster than MGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGNXXNCR
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVUHF0.070.01
+24.51%
SRIVARU Holding Limited
NWVCF0.280.01
+5.56%
EnWave Corp.
XPPLF12.21N/A
N/A
XP Power Ltd.
SMORF1.25N/A
N/A
Smoore International Holdings Ltd.
HSQVY10.50-0.15
-1.41%
Husqvarna AB

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+6.79%
XNCR - MGNX
53%
Loosely correlated
+0.97%
RGNX - MGNX
52%
Loosely correlated
+1.91%
CRBU - MGNX
51%
Loosely correlated
+14.20%
BEAM - MGNX
50%
Loosely correlated
+0.37%
FATE - MGNX
50%
Loosely correlated
+4.96%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+0.97%
CRNX - XNCR
63%
Loosely correlated
-0.56%
DYN - XNCR
58%
Loosely correlated
+2.36%
SYRE - XNCR
57%
Loosely correlated
+2.76%
CGON - XNCR
56%
Loosely correlated
+0.38%
ERAS - XNCR
55%
Loosely correlated
-3.26%
More